###begin article-title 0
###xml 0 9 <span type="species:ncbi:7955">Zebrafish</span>
###xml 21 26 <span type="species:ncbi:9606">human</span>
Zebrafish models for human FKRP muscular dystrophies
###end article-title 0
###begin p 1
###xml 570 579 <span type="species:ncbi:7955">Zebrafish</span>
###xml 716 725 <span type="species:ncbi:7955">zebrafish</span>
###xml 836 841 <span type="species:ncbi:9606">human</span>
###xml 1211 1216 <span type="species:ncbi:9606">human</span>
###xml 1404 1409 <span type="species:ncbi:9606">human</span>
###xml 1460 1465 <span type="species:ncbi:9606">human</span>
###xml 1466 1474 <span type="species:ncbi:9606">patients</span>
###xml 1592 1597 <span type="species:ncbi:9606">human</span>
###xml 1668 1674 <span type="species:ncbi:9606">humans</span>
Various muscular dystrophies are associated with the defective glycosylation of alpha-dystroglycan and are known to result from mutations in genes encoding glycosyltransferases. Fukutin-related protein (FKRP) was identified as a homolog of fukutin, the defective protein in Fukuyama-type congenital muscular dystrophy (FCMD), that is thought to function as a glycosyltransferase. Mutations in FKRP have been linked to a variety of phenotypes including Walker-Warburg syndrome (WWS), limb girdle muscular dystrophy (LGMD) 2I and congenital muscular dystrophy 1C (MDC1C). Zebrafish are a useful animal model to reveal the mechanism of these diseases caused by mutations in FKRP gene. Downregulating FKRP expression in zebrafish by two different morpholinos resulted in embryos which had developmental defects similar to those observed in human muscular dystrophies associated with mutations in FKRP. The FKRP morphants showed phenotypes involving alterations in somitic structure and muscle fiber organization, as well as defects in developing eye morphology. Additionally, they were found to have a reduction in alpha-dystroglycan glycosylation and a shortened myofiber length. Moreover, co-injection of fish or human FKRP mRNA along with the morpholino restored normal development, alpha-dystroglycan glycosylation and laminin binding activity of alpha-dystroglycan in the morphants. Co-injection of the human FKRP mRNA containing causative mutations found in human patients of WWS, MDC1C and LGMD2I could not restore their phenotypes significantly. Interestingly, these morphant fish having human FKRP mutations showed a wide phenotypic range similar to that seen in humans.
###end p 1
###begin title 2
INTRODUCTION
###end title 2
###begin p 3
###xml 496 497 496 497 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP528C1">1</xref>
###xml 718 719 711 712 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP528C2">2</xref>
###xml 880 881 869 870 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP528C2">2</xref>
###xml 882 883 871 872 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP528C5">5</xref>
###xml 370 375 <span type="species:ncbi:9606">human</span>
###xml 463 467 <span type="species:ncbi:10090">mice</span>
Several muscular dystrophies have been associated with glycosylation defects of dystroglycan. Dystroglycan is a central component of the dystrophin-glycoprotein complex (DGC), a large protein complex essential for maintaining the integrity of the sarcolemma by connecting components of the extracellular matrix (ECM) to the internal cytoskeleton of the muscle fiber. No human diseases have been associated with the dystroglycan gene mutations. However, dag1-null mice showed embryonic lethality (1), suggesting that dystroglycan function is critical for normal embryogenesis. Mature dystroglycan consists of two isoforms (alpha- and beta- dystroglycan) generated by post-translational cleavage of a precursor protein (2). Additionally, alpha-dystroglycan subunit is capable of binding to a variety of laminin isoforms and the proteoglycan molecules agrin, perlecan and neurexins (2-5).
###end p 3
###begin p 4
###xml 261 262 257 258 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP528C6">6</xref>
###xml 263 265 259 261 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP528C13">13</xref>
###xml 499 501 495 497 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP528C14">14</xref>
###xml 538 540 534 536 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP528C15">15</xref>
###xml 699 701 695 697 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP528C16">16</xref>
###xml 842 843 838 839 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP528C6">6</xref>
###xml 844 845 840 841 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP528C7">7</xref>
###xml 997 999 993 995 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP528C17">17</xref>
Several forms of muscular dystrophy are associated with the defective glycosylation of alpha-dystroglycan and are caused by mutations in six genes encoding putative glycosyltransferases: POMGnT1, POMT1, POMT2, Fukutin, fukutin-related protein (FKRP) and LARGE (6-13). These diseases include severe forms of congenital muscular dystrophy associated with structural brain defects and variable eye involvement such as Fukuyama-type congenital muscular dystrophy (FCMD), muscle-eye-brain (MEB) disease (14) and Walker-Warburg syndrome (WWS) (15). Mutations in the glycosyltransferase genes also cause much milder muscular dystrophies such as the limb girdle muscular dystrophies (LGMD) types 2I and 2K (16). In some cases, a spectrum of disease severity can result from different mutations in any one of these putative glycosyltransferase genes (6,7). The pathology of these disorders has been attributed to the failure of the resulting hypoglycosylated dystroglycan to bind to components of the ECM (17).
###end p 4
###begin p 5
###xml 76 78 76 78 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP528C13">13</xref>
###xml 79 81 79 81 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP528C18">18</xref>
###xml 528 530 524 526 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP528C19">19</xref>
###xml 879 881 875 877 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP528C18">18</xref>
###xml 1050 1052 1046 1048 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP528C18">18</xref>
###xml 1053 1055 1049 1051 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP528C20">20</xref>
###xml 1056 1058 1052 1054 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP528C21">21</xref>
###xml 1182 1184 1178 1180 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP528C22">22</xref>
###xml 1185 1187 1181 1183 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP528C23">23</xref>
FKRP was identified as a homolog of fukutin, the defective protein on FCMD (13,18). The primary protein sequence predicted from the gene sequence indicates homology to a class of proteins that are thought to function as glycosyltransferases, specifically mediating O-linked glycosylation. The role of FKRP in the glycosylation of alpha-dystroglycan remains unclear. FKRP has been proposed as a putative glycosyltransferase based on similar sequences to other glycosyltransferases; however, this activity has not been confirmed (19). Mutations in FKRP have been linked to variable phenotypes including congenital muscular dystrophy, also referred to as MDC1C, and LGMD2I that may or may not be accompanied by dilated cardiomyopathy. The range of phenotypic severity due to FKRP mutations is very large and is not usually observed for other genes involved with muscular dystrophy (18). Some reports of FKRP mutations include descriptions of founder mutations in the European population (826C > A, L276I) and the Tunisian population (1364C > A, A455D) (18,20,21). Moreover, recent reports showed that some mutations in FKRP gene caused WWS (953G > A, C318Y) and MEB (919T > A, Y307N) (22,23).
###end p 5
###begin p 6
###xml 158 160 158 160 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP528C19">19</xref>
###xml 161 163 161 163 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP528C24">24</xref>
###xml 164 166 164 166 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP528C31">31</xref>
###xml 229 231 229 231 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP528C32">32</xref>
###xml 326 328 326 328 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP528C33">33</xref>
###xml 481 483 481 483 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP528C34">34</xref>
###xml 0 9 <span type="species:ncbi:7955">Zebrafish</span>
###xml 173 182 <span type="species:ncbi:7955">zebrafish</span>
###xml 234 243 <span type="species:ncbi:7955">Zebrafish</span>
###xml 298 303 <span type="species:ncbi:9606">human</span>
###xml 465 470 <span type="species:ncbi:9606">human</span>
Zebrafish represent a good model to investigate genes involved in muscle development and degeneration, and they serve as a good model for muscular dystrophy (19,24-31). The zebrafish expresses orthologues of many DGC components (32). Zebrafish have glycosyltransferases with strong homology to the human forms including FKRP (33). Using a morpholino against FKRP, the resulting knocked down morphants showed an abnormal formation of muscle and eye analogous to the human diseases (34). These results demonstrate the possibility of the animal model of dysfunction of this glycosyltransferase.
###end p 6
###begin p 7
###xml 192 194 192 194 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP528C34">34</xref>
###xml 66 75 <span type="species:ncbi:7955">zebrafish</span>
###xml 433 438 <span type="species:ncbi:9606">human</span>
###xml 587 592 <span type="species:ncbi:9606">human</span>
###xml 628 633 <span type="species:ncbi:9606">human</span>
###xml 781 786 <span type="species:ncbi:9606">human</span>
In the present study, we have knocked down FKRP expression in the zebrafish using two different morpholinos and obtained the same phenotypes in the resulting morphants as previously reported (34). FKRP morphant embryos show defects in muscle organization, eye development and reduction in alpha-dystroglycan glycosylation. In addition, co-injection of a control FKRP mRNA or mutated FKRP mRNAs either corrected pathology or mimicked human clinical conditions. Interestingly, the developmental symptoms in the FKRP morphant were restored by injection of control FKRP mRNA, not by mutated human FKRP mRNAs. Moreover, injection of human FKRP restored the reduction of alpha-dystroglycan glycosylation and laminin binding to alpha-dystroglycan. Our data suggest that the fish model of human FKRP mutations is useful to investigate the pathogenesis associated with the FKRP gene and serves to elucidate the role of FKRP in developmental processes associated with the glycosylation of alpha-dystroglycan.
###end p 7
###begin title 8
RESULTS
###end title 8
###begin title 9
FKRP morphant morphology
###end title 9
###begin p 10
###xml 967 969 967 969 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP528C34">34</xref>
###xml 46 55 <span type="species:ncbi:7955">zebrafish</span>
We began the study of the function of FKRP in zebrafish embryo development by using two anti-sense morpholino oligonucleotides (MO) to disrupt the translation of FKRP mRNA during development. MO1 and MO2 were targeted to regions containing the 5'-untranslated region (MO2) and the start codon of fish FKRP mRNA (MO1). The binding regions of MO1 and MO2 were not overlapping. At 1 dpf, FKRP morphant injected FKRP MO1 (6 ng) and FKRP morphant injected FKRP MO2 (6 ng) had abnormal formation of their heads and eyes (). Moreover, the organization of their muscles was abnormal in both FKRP morphants compared with controls. FKRP morphants displayed alterations in somite morphology observed as curved somite boundaries that are distinct from the regular v-shaped pattern observed in control MO injected embryos (). At 1 dpf, mildly affected morphant embryos were also found to have curved tails and a slight curvature of the somite boundaries like previously reported (34). At 1 dpf, the frequency of observed abnormalities was correlated with injection of increasing amounts of both FKRP MO1 and 2 ().
###end p 10
###begin p 11
At 4 dpf, the frequency of observed developmental abnormalities was also found to correlate in a dose-dependant fashion with amounts of both FKRP MO1 and 2 injected (). Injection of 6 ng of MO1 resulted in a mixture of different fish phenotypes with approximately40% of injected fish exhibiting developmental abnormalities, 40% appearing normal and 20% of them dead. Fish injected with 3 ng of MO2 also had a mixture of different phenotypes with 40% of injected fish exhibiting developmental abnormalities, 20% appearing normal and 40% of them dead. Injection of control morpholinos to both of MO1 and MO2 (mis-matched at 5 bases; see Materials and Methods) resulted in few observed abnormalities which were likely caused by the injection procedure ().
###end p 11
###begin p 12
###xml 237 238 237 238 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDP528F1">1</xref>
###xml 299 300 299 300 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDP528F1">1</xref>
###xml 444 445 444 445 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDP528F2">2</xref>
###xml 628 629 628 629 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDP528F1">1</xref>
###xml 634 635 634 635 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDP528F2">2</xref>
###xml 757 758 757 758 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDP528F1">1</xref>
###xml 764 765 764 765 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDP528F1">1</xref>
###xml 771 772 771 772 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDP528F2">2</xref>
###xml 1267 1268 1267 1268 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDP528F2">2</xref>
###xml 1406 1415 <span type="species:ncbi:7955">zebrafish</span>
FKRP morphant embryos lacked locomotor activity and did not respond to touch with the normal escape response observed in control embryos. Overall, FKRP morphants appeared to have a smaller eye size compared with controls (arrows in Fig. 1G and I) and many had inflated precardia (arrowheads in Fig. 1G and I). FKRP morphant embryos were also found to have an irregular arrangement of muscle fibers compared with control embryos (arrows in Fig. 2G and I). To better visualize the structure and organization of muscle fibers of the morphants, FKRP morphant and control embryos at 4 dpf were analyzed by birefringence assays (Figs 1 and 2). FKRP morphant embryos were found to have markedly reduced normal patterns of birefringence compared with control (Figs 1H and 1J and 2H and I). To confirm the knock down of the expression of fish FKRP with morpholino injection, endogenous FKRP protein was analyzed with antibodies against fish FKRP. In control MO1 and MO2, the FKRP directed antibody recognized 60 kDa protein on western blots, a size predicted by the fish FKRP sequence. The analysis of morphant 1 and 2 extracts showed that the expression of FKRP protein in morphants was substantially decreased compared with those of control MO1- and MO2-injected fish (Fig. 2K). Western blot results show that the morpholinos used in these injections were effective in knocking down the expression of FKRP during zebrafish development.
###end p 12
###begin p 13
###xml 42 43 42 43 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 48 49 48 49 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 68 69 68 69 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 74 75 74 75 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</bold>
###xml 105 106 105 106 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E</bold>
###xml 111 112 111 112 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</bold>
###xml 142 143 142 143 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G</bold>
###xml 148 149 148 149 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H</bold>
###xml 176 177 176 177 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">I</bold>
###xml 182 183 182 183 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">J</bold>
Head and body in FKRP morphant at 4 dpf. (A and B) wild-type fish. (C and D) Control MO1 injected fish. (E and F) Control MO2 injected fish. (G and H) FKRP MO1 injected fish. (I and J) FKRP MO2 injected fish. (A), (C), (E), (G) and (I) show bright images. (B), (D), (F), (H) and (J) show results of birefringence assay. Arrows show smaller eyes in affected fish. Arrowheads show inflated heart in affected fish. Bar: 100 microm.
###end p 13
###begin p 14
###xml 55 56 55 56 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 61 62 61 62 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 81 82 81 82 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 87 88 87 88 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</bold>
###xml 118 119 118 119 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E</bold>
###xml 124 125 124 125 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</bold>
###xml 155 156 155 156 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G</bold>
###xml 161 162 161 162 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H</bold>
###xml 189 190 189 190 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">I</bold>
###xml 195 196 195 196 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">J</bold>
###xml 427 428 423 424 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">K</bold>
Body and muscle structures in FKRP morphant at 4 dpf. (A and B) Wild-type fish. (C and D) Control MO1 injected fish. (E and F) Control MO2 injected fish. (G and H) FKRP MO1 injected fish. (I and J) FKRP MO2 injected fish. (A), (C), (E), (G) and (I) show bright field pictures. (B), (D), (F), (H) and (J) show results of birefringence assay. Arrows highlight the disorganization of myosepta in FKRP morphants. Bar: 100 microm. (K) Immunoblot of protein extracts of 4 dpf wild-type fish and 4 dpf fish injected with FKRP MO1, MO2, control MO (CMO) 1 and 2.
###end p 14
###begin title 15
Immunohistochemistry with muscle structure's components
###end title 15
###begin p 16
###xml 329 330 319 320 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDP528F3">3</xref>
###xml 619 620 609 610 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDP528F3">3</xref>
To examine the expression of other muscle proteins, antibodies against dystrophin, beta-dystroglycan, alpha-dystroglycan and myosin heavy chain (MHC, slow fiber) were used for immunohistochemistry on the morphant embryos. Dystrophin and beta-dystroglycan expression at the myosepta appeared normal and identical to control (Fig. 3I and J); however, the immunostaining of these antibodies indicated that somite boundaries were misshapen with a curved appearance and a less distinct v-shaped structure as seen in controls with localized variation in reactivity to the antibodies along the lengths of the boundaries (Fig. 3I and J).
###end p 16
###begin p 17
###xml 94 95 94 95 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 96 97 96 97 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</bold>
###xml 111 112 111 112 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E</bold>
###xml 117 118 117 118 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</bold>
###xml 134 135 134 135 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">I</bold>
###xml 136 137 136 137 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L</bold>
Immunostaining of FKRP morphant with antibodies against different muscle protein components. (A-D) wild-type. (E and F) Control MO2. (I-L) FKRP MO2. (A), (E) and (I) show the results of immunostaining with anti-dystrophin. (B), (F) and (J) show the results with the anti beta-dystroglycan antibody. (C), (G) and (K) show the results with anti alpha-dystroglycan. (D), (H) and (L) show with anti-MHC. Arrows indicate the disturbance of myosepta in the FKRP morphant. Arrowheads show the gaps between myofibers at myosepta. Bar: 100 microm.
###end p 17
###begin p 18
###xml 217 219 209 211 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP528C35">35</xref>
###xml 318 319 310 311 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDP528F3">3</xref>
###xml 416 417 408 409 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDP528F3">3</xref>
To investigate the glycosylation of alpha-dystroglycan in FKRP morphant embryos, embryos at 4 dpf were immunostained with the antibody VIA4-1, which reacts specifically to glycosylated isoforms of alpha-dystroglycan (35). At 4 days, VIA4-1 staining was mainly observed in normal embryos at the somite boundaries (Fig. 3C and G). VIA4-1 staining of viable FKRP morphants showed a decreased reactivity to VIA4-1 (Fig. 3K) compared with controls.
###end p 18
###begin p 19
###xml 190 191 190 191 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDP528F3">3</xref>
Staining with anti-MHC demonstrated that the length of the myofibers appeared significantly shorter than the control and the gap between myofibers appeared wider compared with control (Fig. 3L), direct measurements given below.
###end p 19
###begin title 20
###xml 53 58 <span type="species:ncbi:9606">human</span>
Co-injection of normal or mutant mRNAs recapitulates human phenotypes
###end title 20
###begin p 21
###xml 396 397 396 397 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDP528F4">4</xref>
###xml 714 715 714 715 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDP528F4">4</xref>
###xml 849 850 849 850 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDP528F4">4</xref>
###xml 1067 1068 1067 1068 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDP528F4">4</xref>
###xml 1213 1214 1213 1214 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDP528F4">4</xref>
###xml 0 5 <span type="species:ncbi:9606">Human</span>
###xml 249 254 <span type="species:ncbi:9606">human</span>
###xml 603 608 <span type="species:ncbi:9606">human</span>
###xml 813 818 <span type="species:ncbi:9606">human</span>
Human and fish FKRP mRNAs were co-injected with the morpholinos to determine whether they could rescue the developmental phenotypes. FKRP mRNA (100 pg) and 3 ng of FKRP MO2 were co-injected into 1-cell- or 2-cell-stage eggs. Co-injection of fish or human FKRP mRNA with MO was effective in the reduction of the number of fish affected with the developmental phenotype at 1 dpf () and 4 dpf (Fig. 4A). The percentage of affected fish and those which died was reduced compared with MO-injected fish, which indicated a partial rescue of the developmental phenotype by these mRNAs. However, co-injection of human FKRP mRNA bearing mutations was not as effective in the recovery of these developmental phenotypes (Fig. 4A). The percentage of recovered affected fish was variable among L276I-, C318Y- and A455D-mutated human FKRP mRNA injected fish (Fig. 4A). L276I-mutated fish showed generally better developmental rescue of the phenotypes; however, C318Y- and A455D-mutated fish had a high percentage of abnormal embryos similar to morphants with morpholino alone (Fig. 4A). The expression of mutant FKRP proteins bearing a c-myc-tag encoded from the injected FKRP mRNAs was confirmed by anti c-myc antibodies (Fig. 4B).
###end p 21
###begin p 22
###xml 99 100 99 100 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 264 265 264 265 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 423 424 420 421 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 544 545 541 542 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 551 552 548 549 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 587 588 584 585 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 623 624 620 621 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 635 636 632 633 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</bold>
###xml 707 708 704 705 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 714 715 711 712 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 753 754 750 751 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 72 77 <span type="species:ncbi:9606">human</span>
Restoration of normal development of FKRP morphant with co-injection of human and fish FKRP mRNA. (A) Histogram of the percentage of dead, affected fish of morphants and recovered fish. Blue bar shows normal %, yellow shows affected % and gray shows dead fish %. (B) Immunoblot analysis of 4 dpf fish extract with anti c-myc for detection of transcripts from the injected mRNA. beta-Actin is used as the internal control. (C) Analysis of the length between myosepta. Error bars represent standard divisions. Single asterisk indicates Student's t-test P < 0.05. Double asterisks indicate P < 0.01. Triple asterisks indicate P < 0.001. (D) Analysis of the diameter of eye. Single asterisk indicates Student's t-test P < 0.01 and double asterisks indicate P < 0.001.
###end p 22
###begin p 23
###xml 106 107 106 107 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDP528F1">1</xref>
###xml 119 120 119 120 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDP528F2">2</xref>
###xml 523 524 514 515 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 540 541 531 532 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDP528F4">4</xref>
To examine the recovery of normal development in muscle structures and eyes found in FKRP morphants (Figs 1G and I and 2G and I), we measured the results of normal and abnormal development. For muscle somites, the average control distance between myosepta was 85.2 microm. In FKRP control MO, the distance was similar with an average of 82.8 microm. FKRP morphant embryos showed an average distance of 72.4 mum between myosepta. The distance between myosepta in FKRP morphant embryos was significant compared with control (P < 0.001) (Fig. 4C).
###end p 23
###begin p 24
###xml 119 120 119 120 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 136 137 136 137 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDP528F4">4</xref>
###xml 102 107 <span type="species:ncbi:9606">human</span>
###xml 168 173 <span type="species:ncbi:9606">human</span>
###xml 195 200 <span type="species:ncbi:9606">human</span>
Moreover, the normal distance between myosepta could be restored to normal by co-injection of fish or human FKRP mRNA (P < 0.001) (Fig. 4C). However, co-injection with human FKRP mRNA containing human mutant alleles was not as effective in recovery of these myosepta distances.
###end p 24
###begin p 25
###xml 224 225 212 213 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDP528F4">4</xref>
###xml 309 310 297 298 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1187 1188 1151 1152 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDP528F4">4</xref>
###xml 1498 1499 1446 1447 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDP528F4">4</xref>
###xml 332 337 <span type="species:ncbi:9606">human</span>
###xml 456 461 <span type="species:ncbi:9606">human</span>
###xml 534 539 <span type="species:ncbi:9606">human</span>
###xml 807 812 <span type="species:ncbi:9606">human</span>
In wild-type fish embryos, the average eye diameter was 324 microm and in FKRP control MO injected embryos a similar average diameter of 317 microm was observed. FKRP morphants showed an average diameter of 200 microm (Fig. 4D). These measurements indicated that the size of eyes was significantly different (P < 0.01). When normal human or fish FKRP mRNA was co-injected, the reduced diameter of eye was returned to near control diameter (co-injection of human FKRP: 286 microm, fish FKRP: 295 microm). However, with co-injection of human FKRP mRNA with mutant alleles, this recovery to normal diameter was not observed. Moreover, measurements showed that phenotypes (eye diameter and the length between myosepta) of fish co-injected the mutated FKRP mRNA were different between the L276I, C318Y and A455D human FKRP mRNA mutant allele injected fish. L276I-mutated fish showed an intermediate phenotype comparing the length between myosepta (78.2 microm versus control 82.8 microm) and eye diameter (252 microm versus control 324 microm). However, injection of the C318Y- and A455D-mutated mRNAs yielded a similar result to fish completely knocked down for the expression of FKRP (Fig. 4A). The eye diameter and the length between myosepta, for C318Y mutant, was smaller compared with the L276I- and A455D-mutated fish (C318Y mutant: the length between myosepta = 70 microm and eye diameter = 191 microm; A455D mutant: the length between myosepta = 76.4 microm and eye diameter =255 microm) (Fig. 4C and D).
###end p 25
###begin title 26
Recovery of muscle organization and glycosylation of alpha-dystroglycan
###end title 26
###begin p 27
###xml 171 172 171 172 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDP528F5">5</xref>
###xml 281 282 281 282 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDP528F5">5</xref>
###xml 546 547 546 547 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDP528F5">5</xref>
###xml 618 619 618 619 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDP528F5">5</xref>
###xml 727 728 723 724 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDP528F6">6</xref>
###xml 852 853 848 849 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDP528F6">6</xref>
###xml 12 17 <span type="species:ncbi:9606">human</span>
###xml 153 158 <span type="species:ncbi:9606">human</span>
###xml 635 640 <span type="species:ncbi:9606">human</span>
When normal human and/or fish FKRP mRNA was co-injected, birefringence of the fish was restored to normal compared with morphants alone and mutated FKRP human mRNAs (Fig. 5C-E). The normal mRNA co-injected fish had a regularity of myosepta similar to that found in wild-type (Fig. 5C and D). Co-injected L276I mutant mRNAs results in mutant fish having nearly normal birefringence in skeletal muscle compared with other mutant fish embryos. The fish co-injected with the C318Y mutant mRNA had decreased signal and no regularity of myosepta (Fig. 5G). A455D mutant mRNA showed no recovery of normal birefringence (Fig. 5H). When normal human FKRP mRNA was co-injected, the glycosylation of alpha-dystroglycan was restored (Fig. 6C). Co-injection of the L276I mutant mRNA lead to the boundary at myosepta that was sharp compared with other mutants (Fig. 6D). The other two mutant alleles, C318Y and A455D, had weaker glycosylation signals compared with L276I mutant and control fish and very similar to that seen with the morpholino alone.
###end p 27
###begin p 28
###xml 62 63 62 63 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 82 83 82 83 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 99 100 99 100 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 138 139 138 139 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</bold>
###xml 183 184 183 184 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E</bold>
###xml 211 212 211 212 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</bold>
###xml 265 266 265 266 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G</bold>
###xml 319 320 319 320 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H</bold>
###xml 141 146 <span type="species:ncbi:9606">Human</span>
###xml 214 219 <span type="species:ncbi:9606">Human</span>
###xml 268 273 <span type="species:ncbi:9606">Human</span>
###xml 322 327 <span type="species:ncbi:9606">Human</span>
Birefringence assay of various FKRP injected fish at 4 days. (A) Wild-type fish. (B) Control MO2. (C) Normal FKRP mRNA co-injected fish. (D) Human normal FKRP mRNA co-injected fish. (E) FKRP MO2 injected fish. (F) Human mutated FKRP mRNA (L276I) co-injected fish. (G) Human mutated FKRP mRNA (C318Y) co-injected fish. (H) Human mutated FKRP mRNA (A455D) co-injected fish. Bar: 100 microm.
###end p 28
###begin p 29
###xml 120 121 116 117 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 122 123 118 119 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</bold>
###xml 485 486 473 474 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G</bold>
###xml 264 269 <span type="species:ncbi:9606">Human</span>
###xml 309 314 <span type="species:ncbi:9606">Human</span>
###xml 363 368 <span type="species:ncbi:9606">Human</span>
###xml 417 422 <span type="species:ncbi:9606">Human</span>
Glycosylation abnormalities of alpha-dystroglycan and recovery of glycosylation by co-injection of FKRP mRNA with MO2. (A-F) Immunostaining of 4 dpf fish co-injected FKRP mRNA with anti alpha-dystroglycan (VIA4-1). (A) Control MO2. (B) FKRP MO2 injected fish. (C) Human normal FKRP mRNA co-injected fish. (D) Human mutated FKRP mRNA (L276I) co-injected fish. (E) Human mutated FKRP mRNA (C318Y) co-injected fish. (F) Human mutated FKRP mRNA (A455D) co-injected fish. Bar: 100 microm. (G) laminin overlay assay and western blot with alpha- and beta-dystroglycan antibody.
###end p 29
###begin p 30
To investigate the laminin-binding ability of alpha-dystroglycan from FKRP morphant embryos, we examined morphants co-injected control FKRP mRNA and mutated FKRP mRNA, and measured alpha-dystroglycan-binding ability using the laminin overlay assay and immunoblot with anti alpha-dystroglycan.
###end p 30
###begin p 31
###xml 190 191 186 187 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDP528F6">6</xref>
###xml 415 417 407 409 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP528C34">34</xref>
###xml 600 601 588 589 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDP528F6">6</xref>
###xml 799 800 783 784 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDP528F6">6</xref>
###xml 146 151 <span type="species:ncbi:10090">mouse</span>
The binding of laminin to alpha-dystroglycan purified from 4 dpf fish tissue was found to be at a lower molecular weight compared with those from mouse muscle tissue and adult tissues (Fig. 6G, lane 1 and 2). The band was also detected with anti-alpha-dystroglycan (VIA4-1). Alpha-dystroglycan had a lower molecular weight compared with those of adult fish that were previously observed in laminin overlay binding (34). The laminin-binding of alpha-dystroglycan from FKRP morphant embryos was found to be significantly reduced compared with control and control FKRP mRNA injected FKRP morphant (Fig. 6G, lane 3 and 4). Alpha-dystroglycan purified from FKRP morphants co-injected with control FKRP mRNAs showed that the affinity to alpha-dystroglycan was recovered compared with FKRP morphants (Fig. 6G, lane 5).
###end p 31
###begin p 32
###xml 141 142 137 138 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDP528F6">6</xref>
###xml 279 280 275 276 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDP528F6">6</xref>
The binding ability of alpha-dystroglycan from FKRP morphant co-injected L276I mutated FKRP RNA was found to be similar to the control (Fig. 6G, lane 6); however, FKRP morphants co-injected mutated FKRP (C318Y or A455D) showed reduced binding ability compared with control (Fig. 6G, lane 7 and 8).
###end p 32
###begin p 33
###xml 365 366 365 366 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDP528F7">7</xref>
###xml 443 444 443 444 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDP528F7">7</xref>
###xml 516 517 516 517 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDP528F7">7</xref>
###xml 595 596 595 596 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDP528F7">7</xref>
###xml 742 743 742 743 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDP528F7">7</xref>
###xml 840 841 840 841 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDP528F7">7</xref>
###xml 278 283 <span type="species:ncbi:9606">human</span>
###xml 494 499 <span type="species:ncbi:9606">human</span>
In FKRP morphant embryos, the distance between the myosepta was reduced and the gap between myofibers was greater. To examine the nature of the protein structure at the gap, myofibers in mutant fish were examined by immunostaining with anti-MHC and anti-laminin. In control and human normal FKRP mRNA co-injected fish, the myofibers were adjacent at myosepta (Fig. 7A and B). The gaps between myofibers that were found in FKRP morphants (Fig. 7C) were also reduced with the injection of normal human FKRP mRNA (Fig. 7B). The length of myofibers was of similar size to that seen in control (Fig. 7A). Using the L276I mutant allele, the gap was reduced compared with FKRP morphants alone and the other two mutant alleles, C318Y and A455D (Fig. 7D). In C318Y and A455D mutant alleles, the gap was still wide and myofibers were disturbed (Fig. 7E and F) similar to that seen with the FKRP morphant alone.
###end p 33
###begin p 34
###xml 223 224 223 224 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 240 241 240 241 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 285 286 285 286 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 313 314 313 314 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</bold>
###xml 367 368 367 368 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E</bold>
###xml 421 422 421 422 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</bold>
###xml 100 105 <span type="species:ncbi:9606">human</span>
###xml 243 248 <span type="species:ncbi:9606">Human</span>
###xml 316 321 <span type="species:ncbi:9606">Human</span>
###xml 370 375 <span type="species:ncbi:9606">Human</span>
###xml 424 429 <span type="species:ncbi:9606">Human</span>
###xml 505 510 <span type="species:ncbi:9606">human</span>
The gaps between myofibers can be repaired by co-injection of normal FKRP mRNA with MO2 but not all human mutant alleles. Co-immunostaining of 4 dpf fish co-injected FKRP mRNA with anti MHC (green) and anti laminin (red). (A) Control MO2. (B) Human normal FKRP mRNA co-injected fish. (C) FKRP MO2 injected fish. (D) Human mutated FKRP mRNA (L276I) co-injected fish. (E) Human mutated FKRP mRNA (C318Y) co-injected fish. (F) Human mutated FKRP mRNA (A455D) co-injected fish. Bar: 50 microm. In control and human control mRNA co-injected fish, the myofibers are adjacent at myosepta (arrows in A and B); however, FKRP morphant has the gap between myosepta (arrowhead in C). In L276I mutant fish, the gap is also narrowed (arrow in D). In C318Y and A455D mutant fish, there still remain gaps similar to that found in FKRP morphant fish (arrows in E and F).
###end p 34
###begin title 35
DISCUSSION
###end title 35
###begin p 36
###xml 521 523 521 523 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP528C13">13</xref>
###xml 524 526 524 526 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP528C18">18</xref>
###xml 527 529 527 529 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP528C36">36</xref>
###xml 707 709 707 709 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP528C34">34</xref>
###xml 932 934 932 934 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP528C37">37</xref>
###xml 935 937 935 937 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP528C40">40</xref>
###xml 47 56 <span type="species:ncbi:7955">zebrafish</span>
###xml 371 376 <span type="species:ncbi:9606">human</span>
###xml 563 571 <span type="species:ncbi:9606">patients</span>
###xml 577 582 <span type="species:ncbi:9606">human</span>
###xml 811 816 <span type="species:ncbi:9606">human</span>
###xml 817 825 <span type="species:ncbi:9606">patients</span>
###xml 847 855 <span type="species:ncbi:9606">patients</span>
###xml 1111 1116 <span type="species:ncbi:9606">human</span>
Knockdown of FKRP levels by morpholinos during zebrafish development results in a clear disorganization of their skeletal muscle. Abnormalities were not only confined to skeletal muscle but also in neurological tissues including the eye and there were clear heart abnormalities. It is known that mutations in the FKRP gene are associated with a spectrum of neuromuscular human diseases ranging from very mild LGMD2I to severe MDC1C and the most severe types called MEB and WWS with neurological and ocular abnormalities (13,18,36). Similar to what is observed in patients with human mutations, FKRP morphant embryos had reduction in eye diameter and muscle abnormalities, similar to results seen by others (34). These results suggest that FKRP morphants have characteristics which parallel clinical findings in human patients. In LGMD2I and MDC1C patients, clinical findings in muscle and dilated cardiomyopathy have been reported (37-40). The findings in these FKRP morphants suggest that FKRP morphant fish may have the characteristics similar to myopathy, neuropathy and cardiomyopathy system involvement in human disease. Using this fish model, further studies focused on brain, eyes and heart may be useful for understanding the mechanism of diseases in these systems.
###end p 36
###begin p 37
###xml 312 314 304 306 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP528C34">34</xref>
###xml 700 702 676 678 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP528C41">41</xref>
###xml 919 921 895 897 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP528C42">42</xref>
In skeletal muscle, FKRP morphant fish have disturbed glycosylation of alpha-dystroglycan and abnormal muscle structure including myofiber size and an apparent gap at the myosepta. Previous reports have also showed the effects on the glycosylation of alpha-dystroglycan and on binding to the ECM ligand laminin (34). The linking between alpha-dystroglycan and ECM proteins with sugar chain of alpha-dystroglycan is known to be important for supporting stable muscle structures. These structures rely on the effective glycosylation of alpha-dystroglycan and carbohydrate modifications and are either absent or reduced resulting in a predicted decrease in binding of alpha-dystroglycan to its ligands (41). A muscle degenerative phenotype has also been described in morpholino-directed dystroglycan knockdown fish embryos in which there is a disruption of the DGC resulting in abnormalities in muscle fiber organization (42).
###end p 37
###begin p 38
The expression of dystrophin and beta-dystroglycan was normal in the skeletal muscle of FKRP morphant; however, myosepta were irregular and there is a wide gap between myofibers when compared with the control. These findings indicate that modification of sugar chains on alpha-dystroglycan may play a critical role in maintaining myosepta length and the spacing between myosepta. The lack of sugar modification likely causes a disconnection between myofibers, and the muscle degeneration decreased upon birefringence.
###end p 38
###begin p 39
###xml 49 54 <span type="species:ncbi:9606">human</span>
###xml 142 147 <span type="species:ncbi:9606">human</span>
###xml 203 209 <span type="species:ncbi:9606">humans</span>
###xml 272 277 <span type="species:ncbi:9606">human</span>
###xml 437 442 <span type="species:ncbi:9606">human</span>
###xml 530 535 <span type="species:ncbi:9606">human</span>
Somewhat surprising was the observation that the human FKRP protein functions to partially restore normal fish muscle structure. In addition, human FKRP mRNA with mutations causing muscular dystrophy in humans is less effective at restoring structure compared with normal human FKRP. This suggests that FKRP functions in the glycosylation of alpha-dystroglycan thus making this model particularly appropriate for studies on the group of human diseases caused by FKRP mutations. This model could also be used to map domains on the human and fish FKRP proteins which are important for normal development and function.
###end p 39
###begin p 40
###xml 318 320 318 320 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP528C18">18</xref>
###xml 51 56 <span type="species:ncbi:9606">human</span>
###xml 194 199 <span type="species:ncbi:9606">human</span>
###xml 200 208 <span type="species:ncbi:9606">patients</span>
###xml 239 246 <span type="species:ncbi:9606">patient</span>
###xml 428 433 <span type="species:ncbi:9606">human</span>
###xml 469 474 <span type="species:ncbi:9606">human</span>
Interestingly, the FKRP morphants co-injected with human FKRP mutations have a wide phenotypic range. In the LGMD2I model fish with L276I mutation, the phenotypes were generally mild similar to human patients with this mutation. In LGMD2I patient, the clinical findings in muscle and heart are mild compared with CMD (18). The reduced abnormalities and laminin binding ability of alpha-dystroglycan in fish co-injected with the human L276I mutation are consistent with human relatively mild clinical finding course.
###end p 40
###begin p 41
###xml 170 172 170 172 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP528C13">13</xref>
###xml 257 259 257 259 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP528C22">22</xref>
###xml 4 13 <span type="species:ncbi:7955">zebrafish</span>
###xml 363 368 <span type="species:ncbi:9606">human</span>
###xml 369 377 <span type="species:ncbi:9606">patients</span>
The zebrafish models exhibited phenotypes similar to the severe CMD and WWS with C318Y and MDC1C with A455D mutations. In MDC1C, the muscle clinical findings are severe (13) and in WWS, the clinical findings include neurological, heart and skeletal muscle (22) and analogous to this. C318Y mutation had abnormalities in eye formation similar to those seen in WWS human patients.
###end p 41
###begin p 42
###xml 40 45 <span type="species:ncbi:9606">human</span>
###xml 237 242 <span type="species:ncbi:9606">human</span>
###xml 287 292 <span type="species:ncbi:9606">human</span>
###xml 487 492 <span type="species:ncbi:9606">human</span>
In conclusion, these fish models of the human disease may be very useful for understanding the pathogenesis of diseases caused by mutations in the FKRP gene. Further investigation using these knockdown fish models and those fish bearing human mutations which yield similar phenotypes to human disease may give clues to the function of FKRP in the glycosylation of alpha-dystroglycan and the maintaining of normal muscle. These studies aid our understanding of the phenotypic spectrum in human muscular dystrophies associated with mutations in the FKRP gene and these fish models are very useful in testing for therapeutic compounds for these muscular dystrophies.
###end p 42
###begin title 43
MATERIALS AND METHODS
###end title 43
###begin title 44
Fish strains and maintenance
###end title 44
###begin p 45
###xml 111 118 111 112 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#176;</bold>
###xml 154 156 148 150 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP528C43">43</xref>
###xml 250 252 244 246 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP528C44">44</xref>
###xml 4 13 <span type="species:ncbi:7955">zebrafish</span>
###xml 60 69 <span type="species:ncbi:7955">Zebrafish</span>
The zebrafish wild-type strain (AB) was used in this study. Zebrafish embryos were collected and raised at 28.5degreesC according to standard procedures (43) and staged in hours or days post-fertilization (hpf or dpf) according to standard criteria (44).
###end p 45
###begin title 46
Anti-sense MO injection
###end title 46
###begin p 47
###xml 601 602 601 602 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 614 615 614 615 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 626 627 626 627 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 632 633 632 633 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 640 641 640 641 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 648 649 648 649 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 650 651 650 651 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 656 657 656 657 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 159 168 <span type="species:ncbi:7955">zebrafish</span>
Anti-sense MO (Gene Tools LLC) targeted to interfere with FKRP translation were designed using the 5' sequence around the putative start of translation of the zebrafish FKRP mRNA (NCBI accession number NM_001042689). The morpholino sequences were FKRP MO 1: 5'-TGGCAAAAACTGATACGCATTATGG-3', FKRP MO 2: 5'-CTTGTGGTTTTATGGCAGAAAGAGT-3'. For control MO, we used two 5 mis-sequence control morpholino, mis-Control MO1: 5'-TGcCAtAAACTcATACcCATTATGc-3', mis-Control MO2: 5'- CTTcTGcTTTTATGcCAcAAAcAGT-3' (five mismatched nucleotides in lower case). Morpholinos were re-suspended in 1x Danieau solution [58 mm NaCl, 0.7 mm KCl, 0.4 mm MgSO4, 0.6 mm Ca (NO3)2, 5 mm HEPES; pH 7.6] with 0.1% phenol red as an injection indicator. Morpholinos were injected into the yolk of one-cell- to two-cell-stage embryos. Embryos were injected with 1.5-12 ng of morpholino depending on experimental condition.
###end p 47
###begin title 48
###xml 11 20 <span type="species:ncbi:7955">zebrafish</span>
###xml 25 30 <span type="species:ncbi:9606">human</span>
Cloning of zebrafish and human FKRP
###end title 48
###begin p 49
###xml 0 9 <span type="species:ncbi:7955">Zebrafish</span>
Zebrafish total RNA was extracted from 1 dpf wild-type embryos and purified with RNeasy micro kit (QIAGEN) and total RNA (500 ng) was converted to cDNA using SuperScript III first-strand system for RT-PCR (Invitrogen) according to the manufacturer's protocol. Primers used to amplify the full-length fish FKRP cDNA coding sequence were forward: 5'-CCATAATGCGTATCAGTTTTTTGCCAGG-3', reverse: 5'-TTCCCAAACAATGCACACAC-3'. The PCR product of the full-length FKRP cDNA was cloned into pGEM easy-T-vector (Stratagene). The FKRP gene sequence was confirmed by sequence analysis and the cDNA then cloned into pcDNA3.1/myc-His C (Invitrogen). PCR products of C-terminal region that amplified sequences with forward primer: 5'-ATGTTTCGGGACAGTTCGAG-3', reverse primer: 5'-CGAGCGGCCGCCGATCCAAATGTGCG-3', were inserted into the fish FKRP cDNA construct in pcDNA 3.1C after digestion with Afe I & Not I (New England Biolads).
###end p 49
###begin p 50
###xml 0 5 <span type="species:ncbi:9606">Human</span>
###xml 150 155 <span type="species:ncbi:9606">human</span>
###xml 247 252 <span type="species:ncbi:9606">human</span>
Human FKRP full-length cDNA was amplified by PCR using a forward primer: 5'- CCAGCTAGCCCCAGACTTC-3', reverse primer: 5'-CTTGGTCAGTTTCCCCCTTC-3' using human normal skeletal muscle cDNA (Invitrogen) as a template. The PCR product of the full-length human FKRP cDNA was cloned into pGEM easy-T-vector (Stratagene). The cDNA clones were sequenced to confirm the fidelity of FKRP sequences. The cDNA was cloned into pcDNA3.1/myc-His C. PCR product of C-terminal sequence amplified by PCR with forward primer: 5'-ACGCCCGCCTACCTCTAC-3', reverse primer: 5'-GGTGACCTCGAGCGCCGCTTCCCGTCAGACTCAGC-3'. The product was ligated into FKRP cDNA in pcDNA3.1/myc-His C after digestion with Xho I (New England Biolads).
###end p 50
###begin p 51
###xml 96 104 <span type="species:ncbi:9606">Children</span>
All PCR products and cloned fragments were sequenced by the Molecular Genetics Core Facility at Children's Hospital Boston using sequencing primers for FKRP sequence analysis ().
###end p 51
###begin title 52
###xml 40 48 40 48 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
Generation of expression constructs and in vitro transcription of RNAs
###end title 52
###begin p 53
###xml 847 848 847 848 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-</bold>
###xml 1009 1012 1009 1012 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Afe</italic>
###xml 1018 1021 1018 1021 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Nco</italic>
###xml 1201 1204 1201 1204 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">sp6</italic>
###xml 5 10 <span type="species:ncbi:9606">human</span>
###xml 132 137 <span type="species:ncbi:9606">human</span>
###xml 277 285 <span type="species:ncbi:9606">patients</span>
###xml 953 958 <span type="species:ncbi:9606">human</span>
Both human and fish FKRP, full-length FKRP mRNAs with myc and His tag constructs were cloned into the pCS2+ expression vector. With human FKRP constructs, two different amino acid substitutions, the same as mutations found MDC1C (1364C > A, A455D) and LGMD2I (826C > A, L276I) patients, were incorporated into the expression vector by site-directed mutagenesis kit (Stratagene). Primers for mutagenesis were forward primer: 5'-GGTGCCCCTGCCCTTTGACGGCTTCGTGG-3', reverse primer: 5'-CCACGAAGCCGTCAAAGGGCAGGGGCACC-3': for the MDC1C causative mutation (1364C > A, A455D). The forward primer: 5'-GGCATCCGCATAGTGAGCTGGGAAGGC-3', reverse primer: 5'-GCCTTCCCAGCTCACTAGGCGGATGCC-3': were used for the LGMD2I causative mutation (826C > A, L276I). For insertion of WWS causative mutation (953G > A, C318Y), the PCR product that amplified by forward primer: 5'-AGCGCTGGACGCCCCCCTGCTACCTGCGCGCGCTGCGCG-3', reverse primer: 5'-GGTCCACGTCGTAGTCCCATGG-3' was inserted to human FKRP cDNA construct in pCS2+ after digestion with AfeI and NcoI. All clones were sequenced to confirm that only the intended mutations were incorporated into the constructs. RNAs were synthesized from Asp718-digested pCS2+ plasmids using the sp6 mMessage mMachine kit (Ambion). The RNAs were quantified by nano drop (Thermo scientific). Phenol red (0.1%) was added to the RNA solution as a tracer, and mRNAs (100 pg) were co-injected into 1-cell-stage embryos with FKRP MO2. Following injection, embryos were cultured in aquatic system at 28.5degreesC.
###end p 53
###begin title 54
Birefringence
###end title 54
###begin p 55
###xml 59 61 59 61 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP528C45">45</xref>
Muscle birefringence was analyzed as previously described (45) by placing anesthesized embryos on a glass polarizing filter and covering the embryos with second polarizing filter. The filters were then placed on an underlit dissecting scope (Nicon, model SMZ1500) and the top polarizing filter twisted until only the light refracting through the striated muscle was visible. Since the degree of birefringence is affected by the horizontal orientation of the fish, the fish were gently oscillated back and forth to account for differences in positioning.
###end p 55
###begin title 56
###xml 0 9 <span type="species:ncbi:7955">Zebrafish</span>
Zebrafish FKRP antibody
###end title 56
###begin p 57
###xml 29 38 <span type="species:ncbi:7955">zebrafish</span>
An antibody directed against zebrafish FKRP was produced by Invitrogen custom service with synthesized peptides (C + NPQYPNPAKKRLDRSR; 517-530) as an antigen. The synthesized peptides were used to absorb the antibodies as a control for specificity of this antibody.
###end p 57
###begin title 58
Immunohistochemistry
###end title 58
###begin p 59
###xml 91 98 91 92 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#176;</bold>
###xml 141 148 135 136 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#176;</bold>
###xml 569 576 550 551 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#176;</bold>
###xml 691 696 <span type="species:ncbi:10090">mouse</span>
###xml 720 726 <span type="species:ncbi:9986">rabbit</span>
For immunohistochemical staining of whole fish, embryos were stored in 100% methanol at -20degreesC after fixation with 4% PFA overnight at 4degreesC. Following rehydration with methanol series (70-50% and PBS-T) and blocking with 2% casein, 1% BSA, 0.05% Tween 20 in PBS to reduce non-specific binding, embryos were incubated separately with the following antibodies: anti-dystrophin (1:100, Sigma), anti beta-dystroglycan (1:100, Novocastra), anti alpha-dystroglycan (1:50, VIA4-1, Millipore), anti-MHC (1:50, F59, Hybridoma bank) and anti-laminin (1:100, Sigma) at 4degreesC overnight. After washing several times, the samples were incubated with secondary antibodies (1:500, either anti-mouse AlexaFluor-488 or anti-rabbit AlexaFluor-568, Invitrogen). The stained embryos were observed under the dissection scope (Nikon, SMZ1500) with EXFO Fluorescence illumination system, X-Cite 120 (Photonic Solution Inc.), a Nikon Eclipse E-1000 microscope, photographed using a Hamamatsu digital camera, and images were acquired using Openlab software version 3.1.5 (Improvision).
###end p 59
###begin title 60
Measurement of eye diameter and distance between myosepta
###end title 60
###begin p 61
The diameter of the eye of 4 dpf embryos was measured under a dissection scope (Nicon, SMZ1500) with Open lab software (Improvision). The distance between myosepta was measured with Open lab software (Improvision) under the dissection scope (Nikon, SMZ1500) after immunostaining of 4 dpf embryos with anti-beta-dystroglycan. Measurements started near the head for 10 subsequent myosepta.
###end p 61
###begin title 62
Western blotting
###end title 62
###begin p 63
###xml 166 167 166 167 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">g</italic>
###xml 172 179 172 173 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#176;</bold>
###xml 710 721 <span type="species:ncbi:3704">horseradish</span>
###xml 758 764 <span type="species:ncbi:9986">rabbit</span>
###xml 768 773 <span type="species:ncbi:10090">mouse</span>
Dechorinated and deyolked embryos were homogenized in Tris-buffered saline (TBS) containing 2% Triton X-100 and protease inhibitors. Following centrifugation at 14000g at 4degreesC for 20 min, the concentration of protein in supernatants was determined by Bradford method, using a protein assay kit (Bio-rad). Proteins were separated by electrophoresis on 8-16% gradient Tris-glycine gels (Invitrogen) and transferred onto PVDF membrane (Invitrogen). After blocking the membrane in PBS containing 1% BSA, 2% casein, blotted proteins were incubated with primary antibody, anti fish FKRP (1:100), anti c-myc (1:100, BD bioscience) anti beta-actin (1:500, Sigma). After washing, the membranes were incubated with horseradish peroxidase secondary antibody (anti-rabbit or mouse IgG, 1:15000, Invitrogen). Proteins were detected using a western blotting detection kit (Millipore).
###end p 63
###begin title 64
Laminin overlay assay
###end title 64
###begin p 65
###xml 117 119 117 119 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP528C17">17</xref>
###xml 311 318 311 312 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#176;</bold>
###xml 682 683 676 677 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 706 707 700 701 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 717 718 711 712 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 723 724 717 718 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 729 730 723 724 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 735 736 729 730 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 44 49 <span type="species:ncbi:10090">mouse</span>
###xml 162 167 <span type="species:ncbi:4565">wheat</span>
###xml 416 425 <span type="species:ncbi:7955">zebrafish</span>
###xml 455 460 <span type="species:ncbi:10090">mouse</span>
###xml 854 860 <span type="species:ncbi:9986">rabbit</span>
###xml 907 913 <span type="species:ncbi:9986">rabbit</span>
Laminin overlay assays were performed using mouse Engelbreth-Holm-Swarm (EHS) laminin (Sigma) as previous described (17). For the purification of a dystroglycan, wheat germ agglutinin (WGA)-agarose beads (Vector Labs) were added to extracts containing equal amounts of total protein and incubated overnight at 4degreesC followed by elution from WGA beads with SDS sample buffer. Tissue extracts were made from adult zebrafish (4-month-old fish) and adult mouse muscle. Proteins were separated by electrophoresis on 4-12% gradient Tris-glycine gels (Invitrogen) and transferred onto PVDF membrane (Invitrogen). PVDF membranes blotted proteins were blocked in the binding buffer (10 mm triethanolamine, 140 mm NaCl, 1 mm MgCl2, 1 mm CaCl2, pH 7.6) containing 5% non-fat dry milk followed by incubation with laminin overnight. Membranes were incubated with rabbit anti-laminin (1:5000, Sigma) followed by anti-rabbit IgG-HRP (1:15000, Invitrogen). Proteins were detected using a western blotting detection kit (Millipore). For detection of alpha- and beta-dystroglycan, anti-alpha-dystroglycan (1:50, VIA4-1, Millipore) and anti-beta-dystroglycan (1:100, Novocastra) were used.
###end p 65
###begin title 66
SUPPLEMENTARY MATERIAL
###end title 66
###begin p 67
.
###end p 67
###begin title 68
FUNDING
###end title 68
###begin p 69
###xml 29 74 29 74 <funding-source xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">National Institutes of Health Program Project</funding-source>
###xml 95 110 95 110 <award-id xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5P50NS040828-07</award-id>
###xml 127 167 127 167 <funding-source xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bernard F. and Alva B. Gimbel Foundation</funding-source>
###xml 197 259 197 259 <funding-source xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Molecular Genetics Core Facility at Children's Hospital Boston</funding-source>
###xml 274 289 274 289 <award-id xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5P30HD018655-26</award-id>
###xml 309 312 309 312 <funding-source xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NIH</funding-source>
###xml 326 391 326 391 <funding-source xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mental Retardation and Developmental Disabilities Research Center</funding-source>
###xml 233 241 <span type="species:ncbi:9606">Children</span>
This work was supported by a National Institutes of Health Program Project Grant (grant number 5P50NS040828-07 to L.M.K.); the Bernard F. and Alva B. Gimbel Foundation (to L.M.K.). Funding for the Molecular Genetics Core Facility at Children's Hospital Boston (grant number 5P30HD018655-26) was provided by a NIH grant to the Mental Retardation and Developmental Disabilities Research Center (MRDDRC).
###end p 69
###begin title 70
Supplementary Material
###end title 70
###begin title 71
[Supplementary Data]
###end title 71
###begin title 72
ACKNOWLEDGEMENTS
###end title 72
###begin p 73
###xml 286 294 <span type="species:ncbi:9606">Children</span>
###xml 476 484 <span type="species:ncbi:9606">Children</span>
###xml 559 564 <span type="species:ncbi:9606">human</span>
###xml 569 578 <span type="species:ncbi:7955">zebrafish</span>
We would like to acknowledge members of the Kunkel for their experimental advice, help in performing these experiments and the drafting of this manuscript. Specifically, we would like to thank Dr Emanuela Gussoni, Dr Iris Eisenberg, Dr Mathew Alexander, Dr Juan Carlos, MckenzieWessen (Children's Hospital Boston) for their helpful advice. In addition, we are grateful to Chris Lawrence and Jason Best who managed our fish facility. We would also like to thank members of the Children's Hospital Sequencing Facility including Hal Schneider for sequencing the human and zebrafish FKRP PCR products. L.M.K. is an investigator of the Howard Hughes Medical Institute.
###end p 73
###begin p 74
###xml 0 30 0 30 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Conflict of Interest statement</italic>
Conflict of Interest statement. There are no conflicts of interest in regard to this manuscript for any of the authors.
###end p 74
###begin title 75
REFERENCES
###end title 75
###begin article-title 76
###xml 96 100 <span type="species:ncbi:10090">mice</span>
DG is essential for early embryonic development: disruption of Reichert's membrane in Dag1-null mice
###end article-title 76
###begin article-title 77
Primary structure of dystrophin-associated glycoproteins linking dystrophin to the extracellular matrix
###end article-title 77
###begin article-title 78
A role for dystrophin-associated glycoprotein complex as a transmembrane linker between laminin and actin
###end article-title 78
###begin article-title 79
A role for dystrophin-associated glycoproteins and utrophin in agrin-induced AchR clustering
###end article-title 79
###begin article-title 80
A stoichiometric complex of neurexins and dystroglycan in brain
###end article-title 80
###begin article-title 81
DG: important player in skeletal muscle and beyond
###end article-title 81
###begin article-title 82
Glyc-O-genetics of Walker-Warburg syndrome
###end article-title 82
###begin article-title 83
Muscular dystrophy and neuronal migration disorder caused by mutations in a glycosyltransferase, POMGnT1
###end article-title 83
###begin article-title 84
Mutations in the O-mannosyltransferase gene POMT1 give rise to the severe neuronal migration disorder Walker-Warburg syndrome
###end article-title 84
###begin article-title 85
POMT2 mutations cause alpha-dystroglycan hypoglycosylation and Walker-Warburg syndrome
###end article-title 85
###begin article-title 86
An ancient retrotransposal insertion causes Fukuyama-type congenital muscular dystrophy
###end article-title 86
###begin article-title 87
###xml 85 90 <span type="species:ncbi:10090">mouse</span>
Mutant glycosyltransferase and altered glycosylation of alpha-DG in the myodystrophy mouse
###end article-title 87
###begin article-title 88
Mutations in the fukutin-related protein gene (FKRP) cause a form of congenital muscular dystrophy with secondary laminin alpha2 deficiency and abnormal glycosylation of alpha-DG
###end article-title 88
###begin article-title 89
###xml 129 134 <span type="species:ncbi:10090">mouse</span>
Skeletal, cardiac and tongue muscle pathology, defective retinal transmission, and neuronal migration defects in the Large (myd) mouse defines a natural model for glycosylation-deficient muscle-eye-brain disorders
###end article-title 89
###begin article-title 90
###xml 65 70 <span type="species:ncbi:10090">mouse</span>
Targeted disruption of the Walker-Warburg syndrome gene Pomt1 in mouse results in embryonic lethality
###end article-title 90
###begin article-title 91
The childhood limb-girdle muscular dystrophies
###end article-title 91
###begin article-title 92
Post-translational disruption of DG-ligand interactions in congenital muscular dystrophies
###end article-title 92
###begin article-title 93
Mutations in the fukutin-related protein gene (FKRP) identify limb girdle muscular dystrophy 2I as a milder allelic variant of congenital muscular dystrophy MDC1C
###end article-title 93
###begin article-title 94
The fukutin protein family-predicted enzymes modifying cell-surface molecules
###end article-title 94
###begin article-title 95
High prevalence and phenotype-genotype correlations of limb girdle muscular dystrophy type 2I in Denmark
###end article-title 95
###begin article-title 96
New FKRP mutations causing congenital muscular dystrophy associated with mental retardation and central nervous system abnormalities. Identification of a founder mutation in Tunisian families
###end article-title 96
###begin article-title 97
Mutations in the FKRP gene can cause muscle-eye-brain disease and Walker-Worburg syndrome
###end article-title 97
###begin article-title 98
###xml 29 37 <span type="species:ncbi:9606">patients</span>
Spectrum of brain changes in patients with congenital muscular dystrophy and FKRP gene mutations
###end article-title 98
###begin article-title 99
###xml 77 86 <span type="species:ncbi:7955">zebrafish</span>
Dystrophin is required for the formation of stable muscle attachments in the zebrafish embryo
###end article-title 99
###begin article-title 100
###xml 4 13 <span type="species:ncbi:7955">zebrafish</span>
The zebrafish as a model for muscular dystrophy and congenital myopathy
###end article-title 100
###begin article-title 101
###xml 68 74 <span type="species:ncbi:9606">humans</span>
###xml 76 80 <span type="species:ncbi:10090">mice</span>
###xml 86 95 <span type="species:ncbi:7955">zebrafish</span>
Diagnosis and cell-based therapy for Duchenne muscular dystrophy in humans, mice, and zebrafish
###end article-title 101
###begin article-title 102
###xml 40 49 <span type="species:ncbi:7955">zebrafish</span>
Delta-sarcoglycan is required for early zebrafish muscle organization
###end article-title 102
###begin article-title 103
###xml 45 54 <span type="species:ncbi:7955">zebrafish</span>
The dystrophin associated protein complex in zebrafish
###end article-title 103
###begin article-title 104
###xml 9 14 <span type="species:ncbi:9606">human</span>
###xml 33 42 <span type="species:ncbi:7955">zebrafish</span>
Modeling human muscle disease in zebrafish
###end article-title 104
###begin article-title 105
###xml 4 13 <span type="species:ncbi:7955">zebrafish</span>
The zebrafish candyfloss mutant implicates extracellular matrix adhesion failure in laminin alpha2-deficient congenital muscular dystrophy
###end article-title 105
###begin article-title 106
###xml 63 72 <span type="species:ncbi:7955">zebrafish</span>
Genetic isolation and characterization of a splicing mutant of zebrafish dystrophin
###end article-title 106
###begin article-title 107
###xml 0 9 <span type="species:ncbi:7955">Zebrafish</span>
###xml 23 28 <span type="species:ncbi:9606">human</span>
Zebrafish orthologs of human muscular dystrophy genes
###end article-title 107
###begin article-title 108
###xml 77 86 <span type="species:ncbi:7955">zebrafish</span>
Genes required for functional glycosylation of dystroglycan are conserved in zebrafish
###end article-title 108
###begin article-title 109
###xml 27 36 <span type="species:ncbi:7955">zebrafish</span>
Developmental defects in a zebrafish model for muscular dystrophies associated with the loss of fukutin-related protein (FKRP)
###end article-title 109
###begin article-title 110
A role for the dystrophin-glycoprotein complex as a transmembrane linker between laminin and actin
###end article-title 110
###begin article-title 111
Phenotypic spectrum associated with mutations in the fukutin-related protein gene
###end article-title 111
###begin article-title 112
The phenotype of limb-girdle muscular dystrophy type 2I
###end article-title 112
###begin article-title 113
Cardiac and respiratory failure in limb-girdle muscular dystrophy 2I
###end article-title 113
###begin article-title 114
Dilated cardiomyopathy may be an early sign of the C826A Fukutin-related protein mutation
###end article-title 114
###begin article-title 115
Cardiac involvement in limb-girdle muscular dystrophy 2I: conventional cardiac diagnostic and cardiovascular magnetic resonance
###end article-title 115
###begin article-title 116
###xml 41 46 <span type="species:ncbi:9606">human</span>
DG: from biosynthesis to pathogenesis of human disease
###end article-title 116
###begin article-title 117
###xml 50 59 <span type="species:ncbi:7955">zebrafish</span>
Removal of DG causes severe muscular dystrophy in zebrafish embryos
###end article-title 117
###begin article-title 118
###xml 39 48 <span type="species:ncbi:7955">zebrafish</span>
Stages of embryonic development of the zebrafish
###end article-title 118
###begin article-title 119
###xml 59 68 <span type="species:ncbi:7955">zebrafish</span>
Genes controlling and mediating locomotion behavior of the zebrafish embryo and larva
###end article-title 119

